Literature DB >> 10378713

A randomized trial of acupuncture as an adjunctive therapy in osteoarthritis of the knee.

B M Berman1, B B Singh, L Lao, P Langenberg, H Li, V Hadhazy, J Bareta, M Hochberg.   

Abstract

OBJECTIVE: The purpose of this study was to investigate the efficacy of acupuncture as an adjunctive therapy to standard care for the relief of pain and dysfunction in elderly patients with osteoarthritis (OA) of the knee.
METHODS: Seventy-three patients with symptomatic OA of the knee were randomly assigned to treatment (acupuncture) or standard care (control). Analysis was performed on last score carried forward to account for patients who dropped out before completion. Patients self-scored Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) and Lequesne indices at baseline and at 4, 8 and 12 weeks. Patients in the control group were offered acupuncture treatment after 12 weeks. The data for these patients are pooled with those from the original acupuncture group for within-group analysis.
RESULTS: Patients randomized to acupuncture improved on both WOMAC and Lequesne indices compared to those who received standard treatment alone. Significant differences on total WOMAC Scale were seen at 4 and 8 weeks. There appears to be a slight decline in effect at 4 weeks after cessation of treatment (12 weeks after first treatment). No adverse effects of acupuncture were reported.
CONCLUSION: These data suggest that acupuncture is an effective and safe adjunctive therapy to conventional care for patients with OA of the knee.

Entities:  

Mesh:

Year:  1999        PMID: 10378713     DOI: 10.1093/rheumatology/38.4.346

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  36 in total

Review 1.  Recent advances: rheumatology.

Authors:  R Madhok; H Kerr; H A Capell
Journal:  BMJ       Date:  2000-10-07

Review 2.  Acupuncture.

Authors:  A Vickers; P Wilson; J Kleijnen
Journal:  Qual Saf Health Care       Date:  2002-03

3.  Effect of a blend of comfrey root extract (Symphytum officinale L.) and tannic acid creams in the treatment of osteoarthritis of the knee: randomized, placebo-controlled, double-blind, multiclinical trials.

Authors:  Doug B Smith; Bert H Jacobson
Journal:  J Chiropr Med       Date:  2011-07-22

Review 4.  Postoperative pain management after total knee arthroplasty in elderly patients: treatment options.

Authors:  Colin J L McCartney; Kathleen Nelligan
Journal:  Drugs Aging       Date:  2014-02       Impact factor: 3.923

Review 5.  Complementary therapies for osteoarthritis: are they effective?

Authors:  Rouzi Shengelia; Samantha J Parker; Mary Ballin; Teena George; M Carrington Reid
Journal:  Pain Manag Nurs       Date:  2012-03-21       Impact factor: 1.929

Review 6.  Evidence-Based Evaluation of Complementary Health Approaches for Pain Management in the United States.

Authors:  Richard L Nahin; Robin Boineau; Partap S Khalsa; Barbara J Stussman; Wendy J Weber
Journal:  Mayo Clin Proc       Date:  2016-09       Impact factor: 7.616

7.  Effects of noninvasive interactive neurostimulation on symptoms of osteoarthritis of the knee: a randomized, sham-controlled pilot study.

Authors:  Terry Kit Selfe; Cheryl Bourguignon; Ann Gill Taylor
Journal:  J Altern Complement Med       Date:  2008-11       Impact factor: 2.579

8.  Antiallodynic effects of acupuncture in neuropathic rats.

Authors:  Myeoung Hoon Cha; Ji Soo Choi; Sun Joon Bai; Insop Shim; Hye-Jung Lee; Sun Mi Choi; Bae Hwan Lee
Journal:  Yonsei Med J       Date:  2006-06-30       Impact factor: 2.759

Review 9.  Acupuncture for peripheral joint osteoarthritis.

Authors:  Eric Manheimer; Ke Cheng; Klaus Linde; Lixing Lao; Junghee Yoo; Susan Wieland; Daniëlle Awm van der Windt; Brian M Berman; Lex M Bouter
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

10.  Ethical Considerations for Acupuncture and Chinese Herbal Medicine Clinical Trials: A Cross-cultural Perspective.

Authors:  Christopher Zaslawski
Journal:  Evid Based Complement Alternat Med       Date:  2008-08-21       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.